ReviewJournal of arrhythmia2025
Perspectives on Clinical Biomarkers Based on the Pathophysiology of Arrhythmias.
Review in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Quantitative Measurement of Extracellular Vesicle-Sized Particles in Blood Plasma by Laser Diffraction Without an Extraction Process: A Proof-of-Concept Study in Atrial Fibrillation.Journal of arrhythmia · 2026Article
- Impaired Atrial Natriuretic Peptide Secretion as a Marker of Advanced Atrial Fibrillation.Circulation reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arrhythmias are diagnosed using electrocardiograms (ECGs). Particularly for paroxysmal arrhythmias, an ECG recorded during an episode is essential for definitive diagnosis. Meanwhile, biomarkers assessable through blood tests do not directly diagnose arrhythmias, but are considered useful for evaluating the prevalence of paroxysmal arrhythmias, predicting their onset, assessing severity, and evaluating the risk of complications. While most biomarker research in the arrhythmia field focuses on atrial fibrillation, several studies have also reported on the prediction of ventricular arrhythmias and sudden death. This paper defines biomarkers as substances measurable and evaluable through blood tests and primarily discusses their relationship with atrial fibrillation and its complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.